NEW YORK, Aug 12 (Reuters) - Johnson & Johnson ( JNJ )

has cleared a key threshold of support for its proposed $6.5

billion settlement of tens of thousands of lawsuits alleging its

baby powder and other talc products caused cancer, according to

a Bloomberg report.

More than 75% of claimants voted in favor of the proposal,

according to Bloomberg, a hurdle the company set for a third

attempt at placing a subsidiary in bankruptcy protection to

resolve the litigation.

J&J spokesperson Clare Boyle said the company could not

comment while the vote tally was not final.